|
Volumn 38, Issue 5, 2007, Pages 385-390
|
Chinese traditional medicine: The status in USA and FDA regulations
|
Author keywords
Chinese traditional medicine; FDA; Regulations; USA
|
Indexed keywords
ANDROSTENEDIONE;
CHONDROITIN SULFATE;
COMFREY EXTRACT;
GINKGO BILOBA EXTRACT;
GLUCOSAMINE SULFATE;
HERBACEOUS AGENT;
HYPERICUM PERFORATUM EXTRACT;
KAVA EXTRACT;
NATURAL PRODUCT;
SABAL EXTRACT;
ACUPUNCTURE;
ALTERNATIVE MEDICINE;
CARTILAGE;
CHINESE MEDICINE;
CLINICAL TRIAL;
COMFREY;
DANGEROUS GOODS;
DEMENTIA;
DEPRESSION;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG RESEARCH;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GERMANDER;
GINKGO BILOBA;
GOOD CLINICAL PRACTICE;
GOOD MANUFACTURING PRACTICE;
HUMAN;
INTERNET;
KNEE ARTHRITIS;
LOBELIA;
LUNG CANCER;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MEDICINAL PLANT;
PANCREAS CANCER;
PATIENT CARE;
PROSTATE HYPERTROPHY;
PUBLIC HEALTH SERVICE;
REVIEW;
SABAL;
SHARK;
UNITED STATES;
|
EID: 36048939627
PISSN: 10005048
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (0)
|